Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern

Neurogastroenterology and Motility

Volumn 26, Issue 1, 2014, Pages 36-45

  Su, A M ^a,b   Shih, W ^c   Presson, A P ^c,d   Chang, L ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abdominal pain; Constipation; Diarrhea; Irritable bowel syndrome; Mixed bowel habits

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DEFECATION HABIT; DIARRHEA; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HARD FECES; HEARTBURN; HUMAN; IRRITABLE COLON; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; NAUSEA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ABDOMINAL PAIN; CONSTIPATION; DIARRHEA; IRRITABLE BOWEL SYNDROME; MIXED BOWEL HABITS;

ABDOMINAL PAIN; ADULT; CONSTIPATION; DEFECATION; DIARRHEA; FEMALE; HABITS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUESTIONNAIRES; YOUNG ADULT;

EID: 84890137978     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12220     Document Type: Article

References (29)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Drossman DA, Morris CB, Hu Y et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005; 128: 580-9.
3. Mearin F, Balboa A, Badia X et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003; 15: 165-72.
4. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
5. Spiller RC, Meyers NL, Hickling RI. Identification of patients with non-d, non-C irritable bowel syndrome and treatment with renzapride: an exploratory, multicenter, randomized, double-blind, placebo-controlled clinical trial. Dig Dis Sci 2008; 53: 3191-200.
6. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-21, e4.
7. Drossman DA, Corazziari E, Talley NJ, Thompson GW, Whitehead WE. Rome II: The Functional Gastrointestinal Disorders. McLean: Degnon Associates Inc, 2000.
8. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990; 300: 439-40.
9. Probert CS, Emmett PM, Cripps HA, Heaton KW. Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome. Gut 1994; 35: 1455-8.
10. Tillisch K, Labus JS, Naliboff BD et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 896-904.
11. Schmulson M, Vargas JA, Lopez-Colombo A, Remes-Troche JM, Lopez-Alvarenga JC. [Prevalence and clinical characteristics of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric trial. A report from the Mexican IBS Working Group.]. Rev Gastroenterol Mex 2010; 75: 427-38.
12. Yao X, Yang YS, Cui LH et al. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol 2012; 27: 760-5.
13. Jamali R, Jamali A, Poorrahnama M et al. Evaluation of health related quality of life in irritable bowel syndrome patients. Health Qual Life Outcomes 2012; 10: 12.
14. Chey WD, Pare P, Viegas A, Ligozio G, Shetzline MA. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. Am J Gastroenterol 2008; 103: 1217-25.
15. Guidance for Industry Irritable Bowel Syndrome - Clinical Evaluation of Drugs for Treatment. In: U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), eds. Silver Spring: U.S. Food and Drug Administration, 2012.
16. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
17. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983; 17: 33-44.
18. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
19. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-66.
20. Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med 2007; 69: 89-98.
21. Ware J, Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33.
22. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
23. Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Am J Gastroenterol 2011; 106: 1813-20.
24. Bijkerk CJ, de Wit NJ, Stalman WA, Knottnerus JA, Hoes AW, Muris JW. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 2003; 17: 363-8; quiz 405-6.
25. Ringel Y, Williams RE, Kalilani L, Cook SF. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2009; 7: 68-72; quiz 3.
26. Lembo T, Naliboff B, Munakata J et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94: 1320-6.
27. Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999; 94: 2929-35.
28. Palsson OS, Baggish JS, Turner MJ, Whitehead WE. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol 2012; 107: 286-95.
29. Manning AP, Wyman JB, Heaton KW. How trustworthy are bowel histories? Comparison of recalled and recorded information. Br Med J 1976; 2: 213-4.